13F filer · CIK 1515070
Tetragon Partners GP Ltd
GRAND CAYMAN, E9 · filing since Q2 2013 · last filing Aug 13, 2026
Reported value
$635.1M
+$119.9M vs prior
Positions
39
New / sold out
10 / 7
Added / reduced
16 / 5
Turnover
6.4%
buys $132.0M · sells $37.1M
Top-10 weight
74.0%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | UIPATH INC | +5,742,372 | +22.8% | +$62.4M |
| New | ALKAMI TECHNOLOGY INC | +600,284 | – | +$10.9M |
| Added | RELAY THERAPEUTICS INC | +388,768 | +214.1% | +$7.3M |
| New | CELCUITY INC | +64,110 | – | +$6.7M |
| Added | IONIS PHARMACEUTICALS INC | +55,409 | +132.7% | +$4.4M |
| Added | DEFINIUM THERAPEUTICS INC | +86,996 | +43.5% | +$4.1M |
| New | ULTRAGENYX PHARMACEUTICAL INCALL | +100,000 | – | +$3.3M |
| New | SILENCE THERAPEUTICS PLCCALL | +300,000 | – | +$3.3M |
| Added | MBX BIOSCIENCES INC | +58,063 | +39.9% | +$3.2M |
| Added | HARMONY BIOSCIENCES HLDGS IN | +81,696 | +68.5% | +$3.0M |
16 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | WARNER BROS DISCOVERY INC | -673,725 | -72.9% | $-18.0M |
| Sold out | PRAXIS PRECISION MEDICINES I | -15,952 | -100.0% | $-5.1M |
| Sold out | SOLENO THERAPEUTICS INC | -102,125 | -100.0% | $-3.4M |
| Sold out | AXSOME THERAPEUTICS INC. | -20,059 | -100.0% | $-3.4M |
| Sold out | MAPLIGHT THERAPEUTICS INC | -112,115 | -100.0% | $-2.3M |
| Sold out | AARDVARK THERAPEUTICS INC | -316,621 | -100.0% | $-1.2M |
| Reduced | NEKTAR THERAPEUTICS | -16,041 | -15.6% | $-1.1M |
| Sold out | ULTRAGENYX PHARMACEUTICAL IN | -39,473 | -100.0% | $-827.0K |
| Reduced | CELLDEX THERAPEUTICS INC NEW | -21,875 | -7.0% | $-814.0K |
| Reduced | AMYLYX PHARMACEUTICALS INC | -19,951 | -6.3% | $-358.3K |
2 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | UIPATH INCCL A | 30,950,000 | $336.4M | 52.98% |
| 2 | KOLIBRI GLOBAL ENERGY INCCOM NEW | 6,834,504 | $33.8M | 5.33% |
| 3 | AUTOLUS THERAPEUTICS LTDSPON ADS | 9,500,000 | $15.2M | 2.39% |
| 4 | LYFT INCCL A COM | 1,000,000 | $14.6M | 2.30% |
| 5 | DEFINIUM THERAPEUTICS INCCOM SHS | 286,990 | $13.5M | 2.13% |
| 6 | WORKIVA INCCOM CL A | 250,000 | $12.1M | 1.91% |
| 7 | SPRINKLR INCCL A | 2,200,000 | $11.4M | 1.79% |
| 8 | MBX BIOSCIENCES INCCOM | 203,543 | $11.2M | 1.77% |
| 9 | ALKAMI TECHNOLOGY INCCOM | 600,284 | $10.9M | 1.71% |
| 10 | CELLDEX THERAPEUTICS INC NEWCOM NEW | 290,441 | $10.8M | 1.70% |
29 more rows. Subscribe for $29/month to see every row, download the data and use the API.